Navigation Links
Claim Filed Against the Company and Nine Other Defendants in the Haifa Magistrates Court
Date:9/2/2007

HAIFA, Israel, Sept. 2 /PRNewswire/ -- Oil Refineries Ltd. (TASE: ORL) (the "Company" or "ORL"), Israel's largest oil refiner, announced today that it has received a claim (the "Claim"), filed with the Haifa District Court by 17 soldiers and fighters in various IDF units, against the Company and nine other defendants. The Claim was filed regarding cancer and other diseases, which the plaintiffs allege they contracted due to their being in the Kishon River during the course of their military service, at different periods, from the 1950s through to the 1990s.

At this preliminary stage it can be noted that the claims, alleged in the Claim, as well as the legal and factual circumstances relating to the Claim as a whole, are similar to previous claims filed by previous groups of soldiers and fighters, as outlined in the Company's financial statements for 2006, as updated in the financial statements as of June 30, 2007. For additional information on this matter please refer to Note 16 B(2) of the Company's financial statements for the year ending December, 31, 2006 and to Note 6(2) of the Company's financial statements for the period ending June 30, 2007.

About Oil Refineries Ltd.

Oil Refineries Ltd. (ORL), located in the bay area of the city of Haifa, is Israel's largest oil refinery. ORL operates sophisticated and state-of- the-art industrial facilities with refining capacity of 9 million tons of crude oil per year, with a Nelson complexity index of 7.4, providing a variety of quality products used in industrial operation, transportation, private consumption, agriculture and infrastructure. The company is also active in the area of Aromatics and Polymers through wholly-owned Gadiv Petrochemical Industries Ltd. and 50% owned Carmel Olefins Ltd. ORL is traded on the Tel Aviv Stock Exchange under the ticker ORL. For additional information please visit the Company's website: http://www.orl.co.il


'/>"/>
SOURCE Oil Refineries Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Ebola Virus - Outbreak Claims More Lives In Uganda.
2. Researchers at Cornell University as been reported using research fund by false claims
3. Health Authorities Claim Some Relief likely from Post floods diseases in Mumbai
4. Encephalitis claims 46 lives in UP
5. Encephalitis Claims 131 lives in Uttar Pradesh
6. Encephalitis Has Claimed 400 Lives In Uttar Pradesh
7. Dengue Claims 15 Lives In West Bengal
8. Palmist Claims to Diagnose Ailments Looking At Your Palm
9. A Blow To Lycopene Supplements Claim To “Health” Fae
10. British Scientists Doubt Delhi Doctor’s Stem Cell Claim
11. ‘Miracle’ HIV Cure Claim Under Scrutin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, ... University of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) ... program, developed in association with efforts by the American College of Surgeons, U.S. ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... laboratory instruments are critical to ensuring high-quality results and maintaining GMP and USP ... of Laboratory Instruments in accordance with GMP requirements " these requirements are explained. ...
(Date:3/28/2017)... ... 28, 2017 , ... With less than 10,000 dermatologists in the United States ... be limited while the desire to conquer breakouts and eliminate skincare stress is widespread. ... customer online, today released its inaugural survey on the State of Acne in America. ...
(Date:3/28/2017)... ... , ... Columbus OH. Dr. Justin Harper, Founder of Juvly Aesthetics in Ohio ... country to sit on the 2017 National Advisory Board for Allergan’s Facial Aesthetics National ... helped propel the clinic from a small start-up to number 78 in the country ...
(Date:3/28/2017)... ... March 28, 2017 , ... Public relations pros work hard to ... of business channels. , While many results are clear, much of PR is hard ... , When it comes to measurement, firms should always take an all-inclusive approach that ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Israel , March 28, 2017 Emosis ... This new business entity, Emosis Ltd, headquartered in Tel ... of novel assays complementing the mother company existing technology platform and ... and sales development of Emosis kits. ... This strategic move starts building Emosis international footprint. ...
(Date:3/28/2017)... 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a ... commercialization of innovative therapies for the treatment of ... Agency (EMA) has notified the company that the ... Application (MAA) has passed validation, and that the ... MAA for ARX-04 (known as DSUVIA™ in the ...
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
Breaking Medicine Technology: